Hidradenitis Suppurativa (HS)
Now enrolling adults living with moderate-to-severe hidradenitis suppurativa for an investigational treatment study.
What this trial is about
Hidradenitis suppurativa is a painful, chronic skin condition characterized by recurring nodules and abscesses, most commonly in the underarms, groin, and other areas where skin rubs together.
This study evaluates an investigational therapy designed to reduce flare frequency and severity for adults living with HS.
All study-related care — including visits, evaluations, and investigational medication — is provided at no cost.
Eligibility
- Adults age 18 or older
- Diagnosed with HS for at least 6 months
- Active lesions in at least two distinct body areas
- Able to attend visits at our Laguna Niguel clinic
Other considerations
- Currently pregnant, breastfeeding, or planning pregnancy during the trial
- Active systemic infection
- Recent participation in another HS investigational study
Final eligibility is determined by the study team after a screening evaluation.
Your journey, step by step
- 1. Confidential screening call
We'll review your history privately and answer any questions about the study.
- 2. Baseline clinic visit
Full evaluation with our principal investigator. Nothing happens without your informed consent.
- 3. Treatment phase
Regular monitoring visits over several months with study-provided medication and assessments.
- 4. Follow-up phase
Ongoing assessments to measure response and ensure your safety.
Common questions
Is the study confidential?+
Yes. All information you share is protected and used only for the purposes of the study as outlined in your consent.
What if my HS flares during the trial?+
Our team is available between visits. We track flares carefully and provide appropriate care under the study protocol.
How is compensation handled?+
Compensation for your time and travel is discussed transparently before you enroll.
Take the next step.
Share your details below — a coordinator will reach out within 1–2 business days to answer questions and discuss next steps. There's no obligation.